Unitree Robotics IPO Registration Approved: China's Humanoid Robots Enter the Compliance-First Era
On July 1, 2026, the China Securities Regulatory Commission (CSRC) issued an official approval letter, consenting to Unitree Robotics' registration application for an initial public offering and listing on the STAR Market (科创板). The approval is valid for 12 months. On July 2, media outlets including IT之家 reported the news. The "first domestic humanoid robot stock" that the embodied intelligence community had awaited for more than three years had arrived.
Unitree's Fundamentals
The company was founded in August 2016 by Wang Xingxing in Hangzhou, where its headquarters remain. Starting from a quadruped robot a decade ago, Unitree now ranks first globally in quadruped robot sales. It is a National High-Tech Enterprise and a national-level Specialized and Sophisticated "Little Giant" (专精特新「小巨人」). As of June 2025, its total headcount exceeded 1,000 employees — a typical hard-tech company scale, but with far higher density than consumer internet firms.
Technically, Unitree's core moat is full-stack in-house development of the three critical components: joint motors, reducers, and controllers. Officially disclosed key component costs are roughly one-third of imported alternatives. This matters because mechatronic systems account for 60–70% of a humanoid robot's BOM cost — yet Unitree can price whole units at the 100,000 RMB level without burning investor capital. While competitors still rely on imported harmonic reducers, Unitree has shipped G1 and H1 humanoids under 200,000 RMB using its own motors — a rare "cost curve turned positive" signal in the 2025 embodied intelligence track.
Three Industry Implications
1. A valuation anchor for the domestic humanoid robot sector. Unitree's publicly disclosed 2024 revenue was close to 1 billion RMB, with decent gross margins — suggesting an offering valuation likely in the 20–40 billion RMB range. A listed leader shifts the sector's pricing from "PPT valuations" to comparable-company multiples, benefiting everyone downstream, including Galaxy General, Zhiyuan (Agibot), and Fourier Intelligence.
2. Regulatory endorsement of the "in-house core components" path. The CSRC approval comes with a prospectus attachment that lays out Unitree's supply chain, technology provenance, and patents in detail. Once this hardware full-stack route is validated by a public company, followers gain an audited template.
3. The first embodied intelligence company priced "as a manufacturer" on A-shares. Unitree's products are mechatronic hardware plus control software and AI algorithms, with revenue driven mainly by hardware shipments — a fundamentally different valuation model from pure LLM inference service companies. Capital markets will learn to price embodied intelligence firms as robot manufacturers rather than AI companies, constraining the tendency to frame everything as an AGI story.
Risks and What to Watch
To be blunt: an approval is not a listing. The actual prospectus, roadshow, and pricing are still ahead. Unitree's prospectus will disclose R&D spending ratios, sales expense structure, and the revenue split between quadruped and humanoid robots over the past three years — data that will determine its final valuation multiple. Another point: Unitree's core customers are predominantly B2B (university labs, robotics competitions, inspection), with almost no B2C presence. The company has not yet entered true "mass-market consumer robotics." Whether the post-IPO growth curve can shift from B-side orders to C-side consumer products is the next chapter of this story.
Regardless, July 1, 2026 deserves a line in the history of China's embodied intelligence industry.
Source: IT之家, "CSRC Approves Unitree Robotics' STAR Market IPO Registration Application," 2026-07-02, https://www.ithome.com/0/971/790.htm